WuXi AppTec peptide facility receives PMDA approval
With peptides, oligos and peptide conjugates continuing to attract drug developer interest and industry capacity in short supply, WuXi AppTec recently reported its Changzhou site has been approved by Japan’s PMDA [Pharmaceuticals and Medical Devices Agency …